16187778

Source:http://linkedlifedata.com/resource/pubmed/id/16187778

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0036341, umls-concept:C0040329, umls-concept:C0085208, umls-concept:C0085862, umls-concept:C0392335, umls-concept:C1280500, umls-concept:C1299583, umls-concept:C1549571, umls-concept:C1608386
pubmed:issue	9
pubmed:dateCreated	2005-9-28
pubmed:abstractText	The objective of this study was to examine the effects of tobacco abstinence and bupropion treatment on cognitive functioning in adult smokers with schizophrenia in the setting of a randomized, double-blind, placebo-controlled clinical trial of bupropion for smoking cessation.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7801243
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bupropion, http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations, http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Uptake Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Nicotine, http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0160-6689
pubmed:author	pubmed-author:CatherCorinneC, pubmed-author:CulhaneMelissa AMA, pubmed-author:DeckersbachThiloT, pubmed-author:EvinsA EdenAE, pubmed-author:FreudenreichOliverO, pubmed-author:GoffDonald CDC, pubmed-author:GreenMichael FMF, pubmed-author:HendersonDavid CDC, pubmed-author:RigottiNancy ANA, pubmed-author:SchoenfeldDavid ADA
pubmed:issnType	Print
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1184-90
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16187778-Adult, pubmed-meshheading:16187778-Attention, pubmed-meshheading:16187778-Bupropion, pubmed-meshheading:16187778-Cognition Disorders, pubmed-meshheading:16187778-Delayed-Action Preparations, pubmed-meshheading:16187778-Dopamine Uptake Inhibitors, pubmed-meshheading:16187778-Double-Blind Method, pubmed-meshheading:16187778-Female, pubmed-meshheading:16187778-Humans, pubmed-meshheading:16187778-Male, pubmed-meshheading:16187778-Middle Aged, pubmed-meshheading:16187778-Neuropsychological Tests, pubmed-meshheading:16187778-Nicotine, pubmed-meshheading:16187778-Placebos, pubmed-meshheading:16187778-Psychomotor Performance, pubmed-meshheading:16187778-Schizophrenia, pubmed-meshheading:16187778-Schizophrenic Psychology, pubmed-meshheading:16187778-Smoking Cessation, pubmed-meshheading:16187778-Substance Withdrawal Syndrome, pubmed-meshheading:16187778-Tobacco Use Disorder, pubmed-meshheading:16187778-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
pubmed:affiliation	Schizophrenia Program , the Tobacco Treatment and Research Center, Massachusetts General Hospital, Boston, MA 02114, USA. a_eden_evins@hms.harvard.edu
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial